Verrica Pharmaceuticals Inc. (VRCA) Misses Q3 EPS by 5c

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q3 EPS of ($0.43), $0.05 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.

You May Also Be Interested In

• U.S. and Denmark close in on a Greenland deal - Reuters
• OpenAI's Sam Altman to brief the UN Security Council next week - Reuters
• Teva shares Phase 3 data on once-monthly schizophrenia injection